NF-κB as potential target in the treatment of melanoma | Journal of Translational Medicine | Full Text
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients | SpringerLink
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
Frontiers | Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Cells | Free Full-Text | NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction | HTML
What is NF-κB pathway? | MBInfo
Multiple Facets of NF-κB in the Heart | Circulation Research
NF-κB signaling, liver disease and hepatoprotective agents | Oncogene
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
Frontiers | Interplay Between Non-Canonical NF-κB Signaling and Hepatitis B Virus Infection
NF-κB in the crosshairs: Rethinking an old riddle - ScienceDirect
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients | SpringerLink
Can NF-B Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View
Targeting IKK and NF-κB for Therapy - ScienceDirect
Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling | Journal of Neuroscience
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
What is NF-κB pathway? | MBInfo
Inhibition of Nuclear Factor Kappa B (NF-κB):
Curcumin Blocks Cytokine-Mediated NF-κB Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-κB Kinase Activity | The Journal of Immunology
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer | PLOS ONE
Roles for NF-κB in nerve cell survival, plasticity, and disease | Cell Death & Differentiation
NF-kB inhibitors and activators | Abcam
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
